600276.SS

Jiangsu Hengrui Medicine Co Ltd · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$54.60B

PE Ratio

45.66

EV to Ebitda

—

Earnings Yield

2.00%

Revenue (TTM)

$4.80B

Net Income (TTM)

$1.20B

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

13.00%

Profit Margin

25.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$54.60B

Revenue TTM$4.80B

Shares Outstanding6.38B

Float3185548303

Insider Ownership46.00%

Institutional Ownership19.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)13.00%

Rev Growth Est 1Y Forward0.16

EPS Growth (Quarterly YoY)7.00%

EPS Growth Est Quarterly0

FCF Growth (Quarterly YoY)-156.00%

Operations19 fields›

Revenue TTM$4.80B

Gross Margin TTM86.00%

Gross Margin (Quarterly)87.00%

Operating Margin TTM32.00%

Operating Margin (Quarterly)32.00%

Operating Expenses TTM$0.57M

Profit Margin TTM25.00%

Profit Margin (Quarterly)28.00%

Net Income TTM$1.20B

EPS TTM1.22

EPS (Quarterly)0.36

EBIT Margin TTM12.82%

EBITDA Margin TTM29.00%

EBITDA TTM$1.39B

CFO TTM$1.65B

Capex % of Revenue TTM9.00%

Capital Expenditures$436.6M

FCF % of Revenue (Quarterly)26.00%

FCF TTM$1.26B

Efficiency1 fields›

ROA9.00%

Valuation10 fields›

P/E (TTM)45.66

P/E Forward59.52

PEG0.93

P/FCF43.44

EV/Revenues (TTM)9.76

Price To Book5.83

Price to Tangible Book5.83

Earnings Yield2.00%

FCF Yield2.00%

Payout Ratio16.00%

Liquidity6 fields›

Cash Per Share6.31

Current Ratio8.08

Total Assets$10.50B

Total Liabilities$3.98B

Shareholders Equity$9.37B

Interest Expense$0.57M

Yields3 fields›

Payout Ratio16.00%

Earnings Yield2.00%

Buyback Yield6.00%